Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. - Wikidata - wikimedia - TriplyDB

Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.

Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.

http://www.wikidata.org/entity/Q44508741

about

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas Mitogen Activated Protein kinase signal transduction pathways in the prostate NetSlim: high-confidence curated signaling maps An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules.Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma.Mechanisms of the epithelial-mesenchymal transition by TGF-beta Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.Transforming growth factor-β and the hallmarks of cancer.Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β.CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance The role of transforming growth factor beta signaling in messenger RNA stability.c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner.TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway.Altered transforming growth factor-beta signaling in a murine model of thoracic aortic aneurysm The metastasis-promoting roles of tumor-associated immune cells Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function.The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression.Phosphorylated-p38 mitogen-activated protein kinase expression is associated with clinical factors in invasive breast cancer.Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents.Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells.X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression Role of p38 MAP Kinase Signal Transduction in Solid Tumors Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.Functional analysis of keratinocyte and fibroblast gene expression in skin and keloid scar tissue based on deviation analysis of dynamic capabilities.Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Interleukin-6: a multifunctional targetable cytokine in human prostate cancer.Molecular mechanisms of curcumin action: gene expression.Molecular pathways in prostate cancer.The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer Proinflammatory cytokine interleukin-6 in prostate carcinogenesis

P2860

Q24669579-C44E2FB7-605C-4A2C-8C91-7A44F8C8A968 Q24802614-AE611239-8BF8-457F-BC86-7B7105ACDCE8 Q28732508-3F9240CD-4A0B-4D4C-B318-72A43933AB68 Q33483669-8B5AEE67-D9E3-48CA-B93A-92C71EAC837E Q33704284-A3AAE716-D061-4AFC-9D7C-3F73AA94B752 Q33753890-E2F4922B-8E00-467C-803E-5FEB89EE7DDE Q33804105-8E393165-01D5-4334-8A81-E9C294F28EAA Q33902576-A6099E63-F28D-47ED-BBA9-634659A2407C Q34789300-3EBC776A-DCE0-45BC-AC99-B3DD205030BD Q35658799-4AC88FC4-B1B8-4DED-B228-63C6EA6A7BDE Q35678242-3F8C9112-2BDA-4F82-8A9B-63AD9CAD9016 Q35873154-366B921C-116D-4B80-8E65-E4A007E46086 Q36194212-DCE2647B-5A02-4B10-8CAC-3F1FC53CA6AE Q36282200-F8F60A64-0138-4454-921B-97DDF063DE95 Q36360686-4A7EEC04-A29D-410F-B8B8-8C4481D91E2B Q36372596-4F197D96-6C92-4E00-B49D-385A6263264A Q36597152-F51B2DF5-856E-4E6B-BABC-1BA7EC03ACA0 Q36659217-7F675EC2-E4BD-4F2E-888D-B3FD9B401110 Q36756684-992EF504-BE9B-4918-973E-6EFE059F9039 Q36923329-8523EFAD-D7CB-460C-843B-B5F49F27CDC4 Q36952819-31F2CA25-579D-4748-A3DB-E57DC50739B1 Q36972016-C7C76807-1F8F-416A-8CA7-CFC912AF0936 Q37021785-676F79A4-3902-4E30-87D3-5EC179873B22 Q37040558-370C7602-0B66-4450-BEA1-95D45BD6B793 Q37041538-7CE01909-3953-4142-AF36-C6D35D0EA420 Q37056598-39DFBBCD-714F-43C5-9D91-0C8BCAEDA937 Q37073686-B589D4BF-4395-48DA-8D68-2D5C884E5E76 Q37085380-A3EE4685-321C-4E9F-B57A-E396C6FB14F4 Q37088314-E9ED5CF1-4652-4FAD-B49A-8E49C2CDF5AB Q37372003-331AFC2B-F4A4-4455-BFD1-44FB3A7323C7 Q37392558-C90642F7-1604-474D-BFCE-AF3C8725373E Q37580230-BC1A4B09-88DF-4E6D-95E4-71FF3421ACC8 Q37581786-DB38C25B-D000-400C-BD4E-856D0EC63D0B Q37606662-9CA54A3C-C0DE-405F-AB08-A388A9E73B42 Q37615017-30A0DFC2-F7C1-45D1-ACD2-BA1A645B998C Q37888027-CCB28A3D-8EF1-43A4-9FF9-E4DDE236F323 Q38045211-403AE38A-CF97-447E-9331-6A50B0AAA316 Q38166735-BC17630C-5ED1-4958-905C-632119A64ED2 Q38176621-C051BBA7-CCA2-411D-B4B8-910EEC8F4954 Q38265575-4B238C9F-1A5F-4BFE-9C54-2E530FE16654

P2860

Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.

http://www.wikidata.org/entity/Q44508741

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Transforming growth factor-bet ...... K, and Ras signaling pathways.

@en

Transforming growth factor-bet ...... K, and Ras signaling pathways.

@nl

type

label

Transforming growth factor-bet ...... K, and Ras signaling pathways.

@en

Transforming growth factor-bet ...... K, and Ras signaling pathways.

@nl

prefLabel

Transforming growth factor-bet ...... K, and Ras signaling pathways.

@en

Transforming growth factor-bet ...... K, and Ras signaling pathways.

@nl

P1433

Q44508741-C1C4E397-365D-4A99-B3A0-C4B438810A98

P1476

Q44508741-8A2C669F-18B3-493B-B425-153FFC8D880E

P2093

Q44508741-41F2D370-039C-4AF2-88FD-9810840A0624

Q44508741-6066885D-55A8-457A-8085-ACFDB6436365

Q44508741-706BC6C9-5A98-4682-B8B7-8B2E65E2F761

Q44508741-7079A3DD-307E-484F-B32E-10E76F8F24DF

Q44508741-7154F093-CDD1-4900-9DC5-76A218D5964B

Q44508741-8E552ECA-F4C3-4304-8C1E-756AF2D9A747

Q44508741-9FE7C194-1424-41F5-911A-B9E75FCAC8FD

Q44508741-ECB52F43-6D1C-428D-BC67-1990E4D59975

Q44508741-EF639184-FC64-49F0-A3C0-6B92C7AF5192

P2860

Q44508741-0521C680-A950-4AE7-8ECF-95F7DEB94937

Q44508741-0996FA17-954F-4E6E-BBDD-50AF3DE6C439

Q44508741-09FEF8FD-1C02-48A4-9446-35FAA3B05792

Q44508741-1A81CE11-CAA8-4A5C-A44F-9590270FC678

Q44508741-1D0AF6EA-D576-4522-AD95-92B11969F289

Q44508741-1F266E89-B8CE-49F9-A18B-583C6438E7EE

Q44508741-21DBE9F5-8958-4BA9-AC0F-F3387EA157D1

Q44508741-2476C68E-12B2-41CC-AAEA-E89D97961286

Q44508741-287BABF6-A8DE-45D7-A064-BB4A0858059B

Q44508741-28DC3436-5793-4DB0-AEEE-BD00250559E6

P2888

Q44508741-AAEA9C04-B64F-405E-BBAA-F7A085466C38

P304

Q44508741-3F006452-E5C7-4185-BE3D-E7CD093CF56E

P31

Q44508741-8FC8665A-0580-4F4E-8FB5-F4E3637455F9

P356

Q44508741-D3A21815-66FE-46B2-9DA8-D4BCBEBC75D2

P407

Q44508741-D23F7317-83A7-4212-9BE8-DC381B4E8F60

P433

Q44508741-96B3BAB8-A896-4BC1-A30F-502584775D1B

P478

Q44508741-0FA214BD-9BA6-4A99-B81B-EAF3148BCA57

P577

Q44508741-A5524BCE-A3EB-4351-8E88-F636DB9BF66C

P5875

Q44508741-AAB2B38D-F9F6-4E1B-B346-2220E46100D3

P698

Q44508741-334D2958-ABEC-4391-BAA1-1FFF5C2DEE06

P921

Q44508741-7e516618-2ead-4d5b-9d11-80aba8a973e0

Q44508741-A1E27076-645B-4783-B948-AE226E2D8447

P356

P1433

P1476

Transforming growth factor-bet ...... K, and Ras signaling pathways.

@en

P2093

Bum-Joon Park

http://www.w3.org/2001/XMLSchema#string

Byung-Kyu Ryu

http://www.w3.org/2001/XMLSchema#string

Do-Sun Byun

http://www.w3.org/2001/XMLSchema#string

Jae-Il Park

http://www.w3.org/2001/XMLSchema#string

Kwon-Seok Chae

http://www.w3.org/2001/XMLSchema#string

Kyucheol Cho

http://www.w3.org/2001/XMLSchema#string

Min-Goo Lee

http://www.w3.org/2001/XMLSchema#string

Sung-Gil Chi

http://www.w3.org/2001/XMLSchema#string

Yong-Keun Park

http://www.w3.org/2001/XMLSchema#string

P2860

Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription

Interleukin 6 induces the expression of vascular endothelial growth factor

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

Characterization of human FAST-1, a TGF beta and activin signal transducer

Smads bind directly to the Jun family of AP-1 transcription factors

Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein

P2888

P304

4314-4332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206478

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10667825

http://www.w3.org/2001/XMLSchema#string

P698

12853969

http://www.w3.org/2001/XMLSchema#string

P921